Identification of hub genes and potential biomarkers of neutrophilic asthma: evidence from a bioinformatics analysis

References

• Nie X, Wei J, Hao Y, Tao J, Li Y, Liu M, Xu B, Li B. Consistent biomarkers and related pathogenesis underlying asthma revealed by systems biology approach. IJMS. 2019;20(16):4037. doi:10.3390/ijms20164037.
   Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, Gibson P, Ohta K, O’Byrne P, Pedersen SE, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–178. doi:10.1183/09031936.00138707.
   PubMed Web of Science ®Google Scholar
• Medrek SK, Parulekar AD, Hanania NA. Predictive biomarkers for asthma therapy. Curr Allergy Asthma Rep. 2017;17(10):69. doi:10.1007/s11882-017-0739-5.
   PubMed Web of Science ®Google Scholar
• Sánchez-Ovando S, Baines KJ, Barker D, Wark PA, Simpson JL. Six gene and TH2 signature expression in endobronchial biopsies of participants with asthma. Immun Inflamm Dis. 2020;8(1):40–49. doi:10.1002/iid3.282.
   PubMed Web of Science ®Google Scholar
• Ntontsi P, Loukides S, Bakakos P, Kostikas K, Papatheodorou G, Papathanassiou E, Hillas G, Koulouris N, Papiris S, Papaioannou AI, et al. Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: comparison with different sputum phenotypes. Allergy. 2017;72(11):1761–1767. doi:10.1111/all.13184.
   PubMed Web of Science ®Google Scholar
• Agache I. Severe asthma phenotypes and endotypes. Semin Immunol. 2019;46:101301. doi:10.1016/j.smim.2019.101301.
   PubMed Web of Science ®Google Scholar
• Schleich F, Demarche S, Louis R. Biomarkers in the management of difficult asthma. Curr Top Med Chem. 2016;16(14):1561–1573. doi:10.2174/1568026616666151015093406.
   PubMed Web of Science ®Google Scholar
• Santus P, Saad M, Damiani G, Patella V, Radovanovic D. Current and future targeted therapies for severe asthma: managing treatment with biologics based on phenotypes and biomarkers. Pharmacol Res. 2019;146:104296. doi:10.1016/j.phrs.2019.104296.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies. Expert Rev Respir Med. 2018;12(9):733–743. doi:10.1080/17476348.2018.1505507.
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013;41(Database issue):D991–5. doi:10.1093/nar/gks1193.
   PubMed Web of Science ®Google Scholar
• Baines KJ, Simpson JL, Wood LG, Scott RJ, Fibbens NL, Powell H, Cowan DC, Taylor DR, Cowan JO, Gibson PG, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol. 2014;133(4):997–1007. doi:10.1016/j.jaci.2013.12.1091.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007.
   PubMed Web of Science ®Google Scholar
• Radermecker C, Louis R, Bureau F, Marichal T. Role of neutrophils in allergic asthma. Curr Opin Immunol. 2018;54:28–34. doi:10.1016/j.coi.2018.05.006.
   PubMed Web of Science ®Google Scholar
• Kikuchi S, Kikuchi I, Takaku Y, Kobayashi T, Hagiwara K, Kanazawa M, Nagata M. Neutrophilic inflammation and CXC chemokines in patients with refractory asthma. Int Arch Allergy Immunol. 2009;149 Suppl 1(Suppl 1):87–93. doi:10.1159/000211379.
   PubMed Web of Science ®Google Scholar
• Liu X, Yi M, Jin R, Feng X, Ma L, Wang Y, Shan Y, Yang Z, Zhao B. Correlation between oxidative stress and NF-kappaB signaling pathway in the obesity-asthma mice. Mol Biol Rep. 2020;47(5):3735–3744. doi:10.1007/s11033-020-05466-8.
   PubMed Web of Science ®Google Scholar
• Lee PH, Hong J, Jang AS. N-acetylcysteine decreases airway inflammation and responsiveness in asthma by modulating claudin 18 expression. Korean J Intern Med. 2020;35(5):1229–1237. doi:10.3904/kjim.2019.105.
   PubMed Web of Science ®Google Scholar
• Seys SF, Lokwani R, Simpson JL, Bullens DMA. New insights in neutrophilic asthma. Curr Opin Pulm Med. 2019;25(1):113–120. doi:10.1097/MCP.0000000000000543.
   PubMed Web of Science ®Google Scholar
• Shilovskiy IP, Nikolskii AA, Kurbacheva OM, Khaitov MR. Modern view of neutrophilic asthma molecular mechanisms and therapy. Biochemistry (Mosc). 2020;85(8):854–868. doi:10.1134/S0006297920080027.
   PubMed Web of Science ®Google Scholar
• Zhu L-M, Zeng D, Lei X-C, Huang J, Deng Y-F, Ji Y-B, Liu J, Dai F-F, Li Y-Z, Shi D-D, et al. KLF2 regulates neutrophil migration by modulating CXCR1 and CXCR2 in asthma. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165920. doi:10.1016/j.bbadis.2020.165920.
   PubMed Web of Science ®Google Scholar
• Bi HJ, Wang J. Structure and function of CXCR1, CXCR2 and its ligands. J Immunol. 2010;26(12):1091–1095.
   Google Scholar
• Veenstra M, Ransohoff RM. Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller? J Neuroimmunol. 2012; 246(1–2):1–9. doi:10.1016/j.jneuroim.2012.02.016.
   PubMed Web of Science ®Google Scholar
• Petering H, Götze O, Kimmig D, Smolarski R, Kapp A, Elsner J. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood. 1999;93(2):694–702. doi:10.1182/blood.V93.2.694.402k31_694_702.
   PubMed Web of Science ®Google Scholar
• Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases. Theranostics. 2017;7(6):1543–1588. doi:10.7150/thno.15625.
   PubMed Web of Science ®Google Scholar
• David J, Dominguez C, Hamilton D, Palena C. The IL-8/IL-8R axis: a double agent in tumor immune resistance. Vaccines (Basel). 2016;4(3):22. doi:10.3390/vaccines4030022.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Chen O. Identification of biomarkers and pathogenesis in severe asthma by coexpression network analysis. BMC Med Genom. 2021;14(1):51. doi:10.1186/s12920-021-00892-4.
   PubMed Web of Science ®Google Scholar
• Oesterle A, Bowman MA. S100A12 and the S100/Calgranulins: emerging biomarkers for atherosclerosis and possibly therapeutic targets. Arterioscler Thromb Vasc Biol. 2015;35(12):2496–2507. doi:10.1161/ATVBAHA.115.302072.
   PubMed Web of Science ®Google Scholar
• Sattar Z, Lora A, Jundi B, Railwah C, Geraghty P. The S100 protein family as players and therapeutic targets in pulmonary diseases. Pulm Med. 2021;2021:5488591. doi:10.1155/2021/5488591.
   PubMed Web of Science ®Google Scholar
• Kang JH, Hwang SM, Chung IY. S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways. Immunology. 2015;144(1):79–90. doi:10.1111/imm.12352.
   PubMed Web of Science ®Google Scholar
• Demirci G, Zamani A, Yosunkaya Ş, Kilinç İ. Serum S100A12 and S100B proteins are independent predictors of the presence and severity of obstructive sleep apnea. Turk J Med Sci. 2019;49(3):746–754. doi:10.3906/sag-1806-147.
   PubMed Web of Science ®Google Scholar